4.04
price up icon8.02%   0.30
after-market アフターアワーズ: 4.32 0.28 +6.93%
loading

Prime Medicine Inc (PRME) 最新ニュース

pulisher
10:08 AM

Major Stakeholders Make Bold Moves in Prime Medicine Stock! - TipRanks

10:08 AM
pulisher
07:23 AM

Arch venture fund XII buys Prime Medicine shares worth $9.99m - Investing.com

07:23 AM
pulisher
04:38 AM

Prime Medicine's $144.2M Equity Raise and Strategic Implications - AInvest

04:38 AM
pulisher
04:16 AM

Prime Medicine's Strategic Capital Raise: A Catalyst for Gene Editing Innovation and Shareholder Value - AInvest

04:16 AM
pulisher
04:03 AM

Prime Medicine Announces Closing of Public Offering and - GlobeNewswire

04:03 AM
pulisher
04:01 AM

Prime Medicine Secures $144M Funding Boost with Strategic Cystic Fibrosis Foundation Investment - Stock Titan

04:01 AM
pulisher
Jul 31, 2025

JonesTrading Maintains a Buy on Prime Medicine (PRME) - Insider Monkey

Jul 31, 2025
pulisher
Jul 31, 2025

Cathie Wood’s ARK buys Prime Medicine, sells CRISPR stock By Investing.com - Investing.com India

Jul 31, 2025
pulisher
Jul 31, 2025

Cathie Wood’s ARK buys Prime Medicine, sells CRISPR stock - Investing.com

Jul 31, 2025
pulisher
Jul 31, 2025

Prime Medicine Announces $120.2M Public Stock Offering - TipRanks

Jul 31, 2025
pulisher
Jul 31, 2025

Is it the right time to buy Prime Medicine Inc. stockBest Dividend Insights For Fast Growth - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Prime Medicine is selling $125M in stock; Nuvectis stops work on ovarian cancer drug - Endpoints News

Jul 31, 2025
pulisher
Jul 31, 2025

14 Best Biotech Penny Stocks to Buy Right Now - Insider Monkey

Jul 31, 2025
pulisher
Jul 31, 2025

Prime Medicine stock falls after pricing public offering - Investing.com

Jul 31, 2025
pulisher
Jul 31, 2025

Prime Medicine stock falls after pricing public offering By Investing.com - Investing.com South Africa

Jul 31, 2025
pulisher
Jul 31, 2025

Why Did Prime Medicine Plunge 13.01%? Regulatory Setbacks, Partnership Concerns - AInvest

Jul 31, 2025
pulisher
Jul 30, 2025

Prime Medicine's $125M Fundraise: A Strategic Inflection Point for Gene Editing Innovation - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

Prime Medicine's $3.30 IPO: A High-Stakes Bet on Gene Editing's Future - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

Prime Medicine Secures $125M Public Offering with Cystic Fibrosis Foundation Backing - Stock Titan

Jul 30, 2025
pulisher
Jul 30, 2025

Prime Medicine Announces Pricing of Public Offering - GlobeNewswire Inc.

Jul 30, 2025
pulisher
Jul 30, 2025

Prime Medicine announces common stock offering, no amount given - TipRanks

Jul 30, 2025
pulisher
Jul 30, 2025

Prime Medicine Halts Sales Agreement Prospectus - TipRanks

Jul 30, 2025
pulisher
Jul 30, 2025

Prime Medicine falls on stock offering launch - TradingView

Jul 30, 2025
pulisher
Jul 30, 2025

Prime Medicine launches public offering of common stock By Investing.com - Investing.com South Africa

Jul 30, 2025
pulisher
Jul 30, 2025

Prime Medicine launches public offering of common stock - Investing.com Australia

Jul 30, 2025
pulisher
Jul 30, 2025

Form 424B5 Prime Medicine, Inc. - StreetInsider

Jul 30, 2025
pulisher
Jul 30, 2025

Prime Medicine Announces Proposed Public Offering of Common Stock - GlobeNewswire

Jul 30, 2025
pulisher
Jul 30, 2025

Prime Medicine, Inc. (PRME) Now Trades Above Golden Cross: Time to Buy? - Zacks Investment Research

Jul 30, 2025
pulisher
Jul 29, 2025

What makes Prime Medicine Inc. stock price move sharplyCapital Protection Trading Strategies Gain Interest - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

RSI Suggests Rebound May Be Near in Prime Medicine Inc.Secure Return Focused Investment Plan Released - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Is Prime Medicine Inc. the Top Chart Pick This WeekCapital Protection Trading Strategies Gain Interest - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Heatmap Data Shows High Activity in Prime Medicine Inc. SectorStock Portfolio Allocation Guidance for Volatile Markets - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Prime Medicine’s SWOT analysis: gene editing firm faces cash crunch amid strategic shift By Investing.com - Investing.com South Africa

Jul 28, 2025
pulisher
Jul 28, 2025

Prime Medicine’s SWOT analysis: gene editing firm faces cash crunch amid strategic shift - Investing.com

Jul 28, 2025
pulisher
Jul 28, 2025

Intraday Charts Show Spike in Prime Medicine Inc. ActivityShort Term High Yield Stock Tips for Active Traders - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about Prime Medicine Inc.Free Stock Trend Scanner That Work - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is Prime Medicine Inc. company’s growth strategyConsistent double returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

When is Prime Medicine Inc. stock expected to show significant growthBreakthrough investment results - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How many analysts rate Prime Medicine Inc. as a “Buy”Free Investment Portfolio Suggestions - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are Prime Medicine Inc. company’s key revenue driversHigh-impact stock picks - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the risk reward ratio of investing in Prime Medicine Inc. stockOutperformance with explosive growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Prime Medicine Inc. stockAchieve consistent profits with smart trading - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Does Prime Medicine Inc. stock perform well during market downturnsExplosive earnings growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Prime Medicine Inc.Get high-impact stock recommendations now - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

How Prime Medicine Inc. stock performs during market volatilitySmart Return Focused Trading - metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

What drives Prime Medicine Inc. stock priceUnmatched market performance - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Prime Medicine Inc. a good long term investmentFree Capital Growth Strategies - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Is Prime Medicine Inc. stock a good hedge against inflationFree Risk Assessment Services - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 23, 2025

What analysts say about Prime Medicine Inc. stockAccelerated investment success - Autocar Professional

Jul 23, 2025
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
大文字化:     |  ボリューム (24 時間):